Len Kanavy
Director/Board Member bei MERUS N.V.
Vermögen: - $ am 31.03.2024
Profil
Len Kanavy is an Independent Non-Executive Director at Merus NV and a Director at KMK Consulting, Inc. He was previously a Director at the Genentech Access To Care Foundation, the Genentech Patient Foundation, and Senior VP-Commercial Business Operations at Genentech, Inc. He also held the position of Vice President-Commercial Operations at Novartis Pharmaceuticals BV.
Kanavy received his undergraduate degree and MBA from the University of Scranton.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
MERUS N.V.
-.--% | 08.06.2023 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Len Kanavy
| Unternehmen | Position | Beginn |
|---|---|---|
| MERUS N.V. | Director/Board Member | 01.07.2018 |
KMK Consulting, Inc.
 KMK Consulting, Inc. Miscellaneous Commercial ServicesCommercial Services KMK Consulting, Inc. delivers integrated, business-critical research, commercial analytics, and software for the pharmaceutical industry. The private company is based in Morristown, NJ. Partnering with KMK can aid in the commercialization journey. | Director/Board Member | 01.10.2017 |
Ehemalige bekannte Positionen von Len Kanavy
| Unternehmen | Position | Ende |
|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01.08.2016 |
| Genentech Patient Foundation | Director/Board Member | 01.01.2016 |
| Genentech Access To Care Foundation | Director/Board Member | 01.01.2016 |
Novartis Pharmaceuticals BV
 Novartis Pharmaceuticals BV Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals BV is a Dutch company that manufactures pharmaceutical products. The private company is based in Arnhem, Netherlands. | Corporate Officer/Principal | - |
Ausbildung von Len Kanavy
| University of Scranton | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| MERUS N.V. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Novartis Pharmaceuticals BV
Novartis Pharmaceuticals BV Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals BV is a Dutch company that manufactures pharmaceutical products. The private company is based in Arnhem, Netherlands. | Health Technology |
| Genentech Access To Care Foundation | |
KMK Consulting, Inc.
KMK Consulting, Inc. Miscellaneous Commercial ServicesCommercial Services KMK Consulting, Inc. delivers integrated, business-critical research, commercial analytics, and software for the pharmaceutical industry. The private company is based in Morristown, NJ. Partnering with KMK can aid in the commercialization journey. | Commercial Services |
| Genentech Patient Foundation | Miscellaneous |
